November 2013

The Centers for Medicare and Medicaid Services (CMS) issued a notice with comment yesterday, officially scheduled to be published…

The Centers for Medicare and Medicaid Services (CMS) published the Medicare Self-Referral Disclosure Protocol (SRDP) pursuant to…

Under the Physician Payments Sunshine Act (Open Payments), pharmaceutical companies, medical device manufacturers, and medical…

The U.S. Department of Health and Human Services, Office of Inspector General issued a report: "FDA's Clearance of Medical Devices…

Member companies of the Association of the British Pharmaceutical Industry (ABPI) have agreed to amend the ABPI Code of Practice…

Over the years we have noted in our coverage of FDLI's Enforcement and Litigation Conference that DOJ and other officials…

As reported in the Wall Street Journal and Smart Brief: "Businesses are confused as to whether to act now or wait for the U.S.…

With the Physician Payment Sunshine Act period of reporting for 2013 drawing to a close end, it will be critical for all…

The Physician Payment Sunshine Act (Open Payments) Final Rule has not clarified all of the expectations under the law. The…

In May 2010, the Food and Drug Administration's (FDA) Office of Prescription Drug Promotion (OPDP) launched the Bad Ad program.…